129 related articles for article (PubMed ID: 36435233)
1. Rationale and design of BROKEN-SWEDEHEART: a registry-based, randomized, parallel, open-label multicenter trial to test pharmacological treatments for broken heart (takotsubo) syndrome.
Omerovic E; James S; Erlinge D; Hagström H; Venetsanos D; Henareh L; Ekenbäck C; Alfredsson J; Hambreus K; Redfors B
Am Heart J; 2023 Mar; 257():33-40. PubMed ID: 36435233
[TBL] [Abstract][Full Text] [Related]
2. Bivalirudin versus heparin in non-ST and ST-segment elevation myocardial infarction-a registry-based randomized clinical trial in the SWEDEHEART registry (the VALIDATE-SWEDEHEART trial).
Erlinge D; Koul S; Eriksson P; Scherstén F; Omerovic E; Linder R; Östlund OP; Wallentin L; Fröbert O; James S
Am Heart J; 2016 May; 175():36-46. PubMed ID: 27179722
[TBL] [Abstract][Full Text] [Related]
3. Alterations in Cardiac Deformation, Timing of Contraction and Relaxation, and Early Myocardial Fibrosis Accompany the Apparent Recovery of Acute Stress-Induced (Takotsubo) Cardiomyopathy: An End to the Concept of Transience.
Schwarz K; Ahearn T; Srinivasan J; Neil CJ; Scally C; Rudd A; Jagpal B; Frenneaux MP; Pislaru C; Horowitz JD; Dawson DK
J Am Soc Echocardiogr; 2017 Aug; 30(8):745-755. PubMed ID: 28599831
[TBL] [Abstract][Full Text] [Related]
4. Temporarily increased stroke rate after Takotsubo syndrome: need for an anticoagulation?
Abanador-Kamper N; Kamper L; Wolfertz J; Vorpahl M; Haage P; Seyfarth M
BMC Cardiovasc Disord; 2018 Jun; 18(1):117. PubMed ID: 29907089
[TBL] [Abstract][Full Text] [Related]
5. Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial.
Feldman T; Mauri L; Kahwash R; Litwin S; Ricciardi MJ; van der Harst P; Penicka M; Fail PS; Kaye DM; Petrie MC; Basuray A; Hummel SL; Forde-McLean R; Nielsen CD; Lilly S; Massaro JM; Burkhoff D; Shah SJ;
Circulation; 2018 Jan; 137(4):364-375. PubMed ID: 29142012
[TBL] [Abstract][Full Text] [Related]
6. Effects of pharmacological interventions on mortality in patients with Takotsubo syndrome: a report from the SWEDEHEART registry.
Petursson P; Oštarijaš E; Redfors B; Råmunddal T; Angerås O; Völz S; Rawshani A; Hambraeus K; Koul S; Alfredsson J; Hagström H; Loghman H; Hofmann R; Fröbert O; Jernberg T; James S; Erlinge D; Omerovic E
ESC Heart Fail; 2024 Jun; 11(3):1720-1729. PubMed ID: 38454651
[TBL] [Abstract][Full Text] [Related]
7. Intraventricular Thrombus Formation and Embolism in Takotsubo Syndrome: Insights From the International Takotsubo Registry.
Ding KJ; Cammann VL; Szawan KA; Stähli BE; Wischnewsky M; Di Vece D; Citro R; Jaguszewski M; Seifert B; Sarcon A; Knorr M; Heiner S; Gili S; D'Ascenzo F; Neuhaus M; Napp LC; Franke J; Noutsias M; Burgdorf C; Koenig W; Kherad B; Rajan L; Michels G; Pfister R; Cuneo A; Jacobshagen C; Karakas M; Pott A; Meyer P; Arroja JD; Banning A; Cuculi F; Kobza R; Fischer TA; Vasankari T; Airaksinen KEJ; Paolini C; Bilato C; Carrilho-Ferreira P; Opolski G; Dworakowski R; MacCarthy P; Kaiser C; Osswald S; Galiuto L; Dichtl W; Chan C; Bridgman P; Delmas C; Lairez O; El-Battrawy I; Akin I; Gilyarova E; Shilova A; Gilyarov M; Kozel M; Tousek P; Widimský P; Winchester DE; Galuszka J; Ukena C; Horowitz JD; Di Mario C; Prasad A; Rihal CS; Pinto FJ; Crea F; Borggrefe M; Braun-Dullaeus RC; Rottbauer W; Bauersachs J; Katus HA; Hasenfuß G; Tschöpe C; Pieske BM; Thiele H; Schunkert H; Böhm M; Felix SB; Münzel T; Bax JJ; Lüscher TF; Ruschitzka F; Ghadri JR; Bossone E; Templin C
Arterioscler Thromb Vasc Biol; 2020 Jan; 40(1):279-287. PubMed ID: 31766870
[TBL] [Abstract][Full Text] [Related]
8. Phase 3 DREAM-HF Trial of Mesenchymal Precursor Cells in Chronic Heart Failure.
Borow KM; Yaroshinsky A; Greenberg B; Perin EC
Circ Res; 2019 Jul; 125(3):265-281. PubMed ID: 31318648
[TBL] [Abstract][Full Text] [Related]
9. Persistent Long-Term Structural, Functional, and Metabolic Changes After Stress-Induced (Takotsubo) Cardiomyopathy.
Scally C; Rudd A; Mezincescu A; Wilson H; Srivanasan J; Horgan G; Broadhurst P; Newby DE; Henning A; Dawson DK
Circulation; 2018 Mar; 137(10):1039-1048. PubMed ID: 29128863
[TBL] [Abstract][Full Text] [Related]
10. Instantaneous Wave-Free Ratio versus Fractional Flow Reserve guided intervention (iFR-SWEDEHEART): Rationale and design of a multicenter, prospective, registry-based randomized clinical trial.
Götberg M; Christiansen EH; Gudmundsdottir I; Sandhall L; Omerovic E; James SK; Erlinge D; Fröbert O
Am Heart J; 2015 Nov; 170(5):945-50. PubMed ID: 26542503
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the German and Italian Stress Cardiomyopathy Score for Risk Stratification for In-hospital Complications in Patients With Takotsubo Syndrome.
Santoro F; Núñez Gil IJ; Stiermaier T; El-Battrawy I; Guerra F; Novo G; Guastafierro F; Tarantino N; Novo S; Mariano E; Romeo F; Romeo F; Capucci A; Bahlmann E; Zingaro M; Cannone M; Caldarola P; Marchetti MF; Montisci R; Meloni L; Thiele H; Di Biase M; Almendro-Delia M; Sionis A; Akin I; Eitel I; Brunetti ND
JAMA Cardiol; 2019 Sep; 4(9):892-899. PubMed ID: 31389988
[TBL] [Abstract][Full Text] [Related]
12. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
[TBL] [Abstract][Full Text] [Related]
13. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome in patients with Takotsubo syndrome presenting with severely reduced left ventricular ejection fraction.
Citro R; Radano I; Parodi G; Di Vece D; Zito C; Novo G; Provenza G; Bellino M; Prota C; Silverio A; Antonini-Canterin F; Rigo F; Vriz O; Galasso G; Bossone E; Salerno-Uriarte J; Piscione F
Eur J Heart Fail; 2019 Jun; 21(6):781-789. PubMed ID: 30714660
[TBL] [Abstract][Full Text] [Related]
15. Design and rationale of the Danish trial of beta-blocker treatment after myocardial infarction without reduced ejection fraction: study protocol for a randomized controlled trial.
Kristensen AMD; Bovin A; Zwisler AD; Cerquira C; Torp-Pedersen C; Bøtker HE; Gustafsson I; Veien KT; Thomsen KK; Olsen MH; Larsen ML; Nielsen OW; Hildebrandt P; Foghmar S; Jensen SE; Lange T; Sehested T; Jernberg T; Atar D; Ibanez B; Prescott E
Trials; 2020 May; 21(1):415. PubMed ID: 32446298
[TBL] [Abstract][Full Text] [Related]
16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
17. Short- and Long-Term Clinical Outcomes for Patients With Takotsubo Syndrome and Patients With Myocardial Infarction: A Report From the Swedish Coronary Angiography and Angioplasty Registry.
Redfors B; Jha S; Thorleifsson S; Jernberg T; Angerås O; Frobert O; Petursson P; Tornvall P; Sarno G; Ekenbäck C; Ravn-Fisher A; Y-Hassan S; Lyon AR; James S; Erlinge D; Omerovic E
J Am Heart Assoc; 2021 Sep; 10(17):e017290. PubMed ID: 34465127
[TBL] [Abstract][Full Text] [Related]
18. Clinical assessment of Shenfu injection loading in the treatment of patients with exacerbation of chronic heart failure due to coronary heart disease: study protocol for a randomized controlled trial.
Liu C; Hou Y; Wang X; Zhao Z; Liu Z; Zhai J; Mao J; Shang H
Trials; 2015 May; 16():222. PubMed ID: 25994188
[TBL] [Abstract][Full Text] [Related]
19. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.
Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M;
Trials; 2021 Mar; 22(1):172. PubMed ID: 33648568
[TBL] [Abstract][Full Text] [Related]
20. Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy.
Templin C; Ghadri JR; Diekmann J; Napp LC; Bataiosu DR; Jaguszewski M; Cammann VL; Sarcon A; Geyer V; Neumann CA; Seifert B; Hellermann J; Schwyzer M; Eisenhardt K; Jenewein J; Franke J; Katus HA; Burgdorf C; Schunkert H; Moeller C; Thiele H; Bauersachs J; Tschöpe C; Schultheiss HP; Laney CA; Rajan L; Michels G; Pfister R; Ukena C; Böhm M; Erbel R; Cuneo A; Kuck KH; Jacobshagen C; Hasenfuss G; Karakas M; Koenig W; Rottbauer W; Said SM; Braun-Dullaeus RC; Cuculi F; Banning A; Fischer TA; Vasankari T; Airaksinen KE; Fijalkowski M; Rynkiewicz A; Pawlak M; Opolski G; Dworakowski R; MacCarthy P; Kaiser C; Osswald S; Galiuto L; Crea F; Dichtl W; Franz WM; Empen K; Felix SB; Delmas C; Lairez O; Erne P; Bax JJ; Ford I; Ruschitzka F; Prasad A; Lüscher TF
N Engl J Med; 2015 Sep; 373(10):929-38. PubMed ID: 26332547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
